Atlas Trials

Evaluation of 89Zr-DFO-nimotuzumab for Non-invasive Imaging of EGFR+ Cancers by Positron Emission Tomography (PET)

Clinical trial NCT04235114 · RECRUITING

Trial details

NCT number
NCT04235114
Sponsor
University of Saskatchewan
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Lung CancerColorectal Cancer
Start date
2020-02-01
Primary completion
2026-09-01
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.